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012.07.0Abstract Background: The left atrial appendage (LAA) has been considered a relatively signiﬁ-
cant portion of the cardiac anatomy. Transesophageal echocardiography (TEE) is a technique that
makes clear imaging of the LAA possible, so that its shape and function can be assessed. Tissue
Doppler imaging (TDI) was used recently for the assessment of the contractile function of the left
atrial appendage (LAA) and right atrial appendage (RAA).
Patients and methods: Forty-three patients with pure mitral stenosis (MS) in sinus rhythm were
compared to 12 normal individuals only patients with mild and severe mitral stenosis were included.
Patients with moderate mitral stenosis were excluded. A transthoracic and a transesophageal echo
were performed in all patients. We assessed the LAA anatomy (neck width, length, area). Assess-
ment of LAA function was done by the recording of LAA emptying velocity. Pulsed-wave tissue
Doppler imaging (TDI) was positioned at the tip of the LAA and the tip of the RAA to obtain atrial
peak systolic (Sm) and diastolic myocardial velocities.
Results: Patients with MS (severe and mild) had a larger left atrial diameter and area than the con-
trol {50.5 ± 3.8 & 46.2 ± 4.5 vs 35.4 ± 1.8, and 31.2 ± 3.3 & 26 ± 2.3 vs 19.9 ± 1.4} P-value
0.0001 & 0.0001, respectively and patients with MS (severe and mild) had a higher PASP than
the control {50.9 ± 10.5 & 30 ± 7 vs 25.2 ± 1.6} P-value 0.0001. TEE data of patients with MS
(severe and mild) had a larger left atrial appendage length, base, and area than the control
{(49.8 ± 6.38 & 42 ± 2.5 vs 37.8 ± 2.2), (27.7 ± 3.8 & 23.2 ± 3.1 vs 18 ± 2.5), and (7.6 ± 0.6
& 6.5 ± 0.5 vs 4.6 ± 0.7} P-value 0.0001. Patients with MS (severe and mild) had a signiﬁcant
decrease in atrial peak systolic ﬂow velocities (S wave) than the control (16.1 ± 3.7 & 26.5 ± 0.7
vs 70 ± 13), P-value 0.0001.Also patients with MS (severe and mild) had signiﬁcant decrease in
atrial peak systolic myocardial velocities (Sm wave) of the LAA compared with the control0 867554403, mobile: +20
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220 K.S. Mahmoud, M.A. Al Kader(6.1 ± 1.7 & 12.6 ± 0.3 vs 18.8 ± 1.9), P-value 0.0001. (TDI) ﬂow of the RAA myocardial veloc-
ity, patients with mitral stenosis (severe and mild) had a signiﬁcant decrease in atrial peak systolic
myocardial velocities (Sm wave) of the RAA compared with the control (16.5 ± 2.9 & 17.7 ± 1.6 vs
20.1 ± 2.6), P-value 0.0001. SEC was detected in the LAA in 17 patients of the 43 patients with
mitral stenosis which represents 39.5% of the patients. All patients with SEC were with severe
MS. Patients with SEC had a signiﬁcant increase in Fc, mean transmitral gradient, PASP, Sm
LAA, Sm RAA, LAA area and peak S velocity LAA than patients without SEC. No patient
had SEC in the RAA cavity.
Conclusion: LAA and RAA dysfunction occurred in patients with MS and sinus rhythm due to
increase of atrial afterload presented by a decrease in atrial myocardial velocities.
ª 2012 Egyptian Society of Cardiology. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Trans-esophageal echocardiography (TEE) is a moderately
invasive technique that has been shown to have a higher accu-
racy in identifying abnormal lesions in patients with cardio em-
bolic strokes. These include abnormalities of the left atrium
(LA) and right atrium (RA) and appendages.1 The left atrial
appendage (LAA) is an important anatomical region, given
its association with atrial tachyarrhythmias and thrombi.2,3
Recent reports have described the development of technologies
for therapy delivery for this region.4,5 A detailed understand-
ing of the LAA anatomy may facilitate such endeavors.6 The
appendages are the cardiac structures that remain difﬁcult to
examine thoroughly by trans- thoracic echo (TTE). However,
TEE allows for superior imaging of both LAA and right atrial
appendage (RAA).7,8 The incidence of thromboembolism re-
mains high in patients with mitral stenosis (MS). LAA is a po-
tential site for the development of thrombus and LAA
dysfunction is an independent predictor of thromboembolism.9
Among the factors related to the presence of thrombi in the
LAA are its dilation and decrease in contractility with the
ensuing blood stasis, manifested by SEC and low ﬂow veloci-
ties10,11 in the TEE. Several authors have analyzed this con-
tractile dysfunction of the LAA12,13, but little attention has
been paid to the RAA. This is probably due to its location,
which makes it difﬁcult to visualize with monoplane transduc-
ers, while it is almost impossible to assess with transthoracic
echo. In the RAA, the prevalence of thrombi and their embolic
complications are lower than in the LAA.14
2. The aim of the study
The aim of the study was to evaluate anatomical and func-
tional parameters of LAA and RAA in patients with MS
and sinus rhythm.
3. Patients and methods
The current study included 43 patients with pure mitral steno-
sis (MS) who were still in sinus rhythm. It was carried out in
the Cardiology department, El Minia University Hospital,
during the period from January 2007 to January 2011 and
compared them to 12 normal subjects. Five were healthy vol-
unteers and 7 underwent TEE due to suspicion of congenital
heart disease. All patients signed the informed consent. Only
patients with mild (mitral valve area > 1.5 cm2) and severe
(mitral valve area < 1 cm2) mitral stenosis were included.Patients with moderate mitral stenosis were excluded to ex-
plore the differences in both extremes of the whole spectrum
of the disease. A TTE and TEE were performed in all patients.
Patients were divided into 3 groups: group 1 (19 patients with
severe MS, 16 women, 3 men, mean age: 40.1 ± 10.2 years),
group 2 (24 patients with mild MS, 20 women, 4 men, mean
age: 34.8 ± 11.9 years), and group 3 (12 normal individuals,
10 women, 2 men mean age: 41.9 ± 12.8 years).
3.1. Echocardiographic studies
Both TTE and TEE studies were done. All patients were sub-
jected to TTE examination using Doppler echocardiography
unit (GE, Norway, vivid 3 Expert) with a 2.5–3.5 MHz trans-
ducer. Patients were examined in the left lateral decubitus po-
sition. The mitral valve area (MVA) was measured by
continuous wave Doppler on mitral valve at apical four cham-
ber view using the pressure half-time method in cm2 and by 2D
planimetry method. The mean pulmonary artery pressure was
estimated from pulmonary acceleration time of the pulmonary
blood ﬂow. The LA and RA were visualized for the presence of
thrombus and SEC. LA dimension, LVEDD, and ESD and
EF% were measured and calculated from para-sternal M-
mode recordings according to standard criteria.15
3.2. TEE study
All patients were studied in the conscious & fasting state using
10% lidocaine spray and viscous lidocaine gel for posterior
pharyngeal anesthesia. Sedation (midazolam Hydrochloride)
was given only when needed and no atropine was adminis-
tered. The procedure was performed with continuous monitor-
ing of ECG and oxygen saturation using a multi-plane TEE
probe 8T of the same machine. The TEE probe was inserted
with the subject lying in the right lateral position. The TEE
examination was done stressing on the following speciﬁc
measurements:
 The LAA images were visualized at 0 and the RAA at
130 according to the standard recommendations16,17 to
facilitate anatomic assessment and to obtain pulsed Dopp-
ler ﬂow velocity proﬁles immediately within the appendage
base with the transducer tip in the mid-esophagus. We
assessed the LAA anatomy (neck width, length, area)
(Fig. 1). The LAA neck width was measured as a line
drawn from the limbus of the conﬂuence of the left upper
pulmonary vein and the LAA to the outermost portion of
Figure 1 Measurement of LAA neck width and length and Doppler sample site in patient with sinus rhythm by TEE.
Figure 2 Measurement of LAA emptying velocity in patient with sinus rhythm by TEE.
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from the previously identiﬁed conﬂuence point to the
appendage apex. The maximal LAA area was determined
by computer assisted planimetry from the tip of the
appendage to its junction with the main LA body asdescribed previously.18 Assessment of LAA function was
done by the recording of LAA emptying velocity by plac-
ing a pulsed wave Doppler sample volume just inside the
base of the appendage (Fig. 2). LAA emptying ﬂow veloc-
ity was obtained using pulsed Doppler with the lowest
Figure 3 Measurement of RAA neck width and length in a patient with sinus rhythm by TEE.
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tying velocities were determined with the average of 3 car-
diac cycles. The presence or absence of LA thrombi, SEC
or MR was determined by two observers. The presence of
thrombus was diagnosed when an intra-cavitary echo-
dense mass with an echocardiographic appearance differ-
ent from the atrial endocardium and the pectinate muscle
was detected; the presence of SEC was diagnosed when
dynamic swirling, intra-cavitary, and smoke like echoes
were detected and differentiated from white noise artifacts
by their characteristic swirling pattern and by careful
attention to the gain settings.
 The RAA was assessed from the bicaval view where the
entry of both vena cavas to the right atrium was visual-
ized. The neck of the RAA19 was identiﬁed from the con-
ﬂuence of the superior vena cava (SVC) and the body of
the right atrium (RA) until the lateral border of the RA
(Fig. 3). Pulsed Doppler ﬂow velocity proﬁles were
obtained inside of the RAA. Pulsed-wave tissue Doppler
imaging (TDI) was positioned at the tip of LAA and the
tip of the RAA (Fig. 3) with beam angle 10_ to obtain
atrial peak systolic (Sm) and diastolic (Dm) myocardial
velocities.20
To allow off-line quantitative analysis of the echocardio-
graphic data, studies were archived with selected still images,
cine loops and velocity spectra for subsequent analysis and
ﬁnally recorded on CD. LAA and RAA anatomic measure-
ments were taken at the onset of the P wave. All measurements
were made at the prescribed orientation ±10.
3.3. The study exclusion criteria
1. Moderate or severe mitral regurgitation.
2. Moderate mitral stenosis.3. Patients with contraindication to the procedure: esophageal
or pharyngeal obstruction, suspected or known perforated
viscous, gastrointestinal bleeding, and instability of cervical
vertebrae, uncooperative patient, esophageal varices and
bleeding diathesis.
4. Nonrheumatic mitral stenosis.





All analyses were conducted using SPSS Version 11. All group
data are expressed as mean ± standard deviation. For multi-
ple comparisons, we used the ANOVA test for variables with
normal distribution. The comparison of intergroup quantita-
tive variables was performed with Student’s t test. A P value
of <0.05 was considered signiﬁcant.
4. Results
The clinical characteristics of the patients and control are
presented in Table 1. There was no signiﬁcant difference in pa-
tients with mitral stenosis and control as regards age, sex, and
heart rate. Patients with severe mitral stenosis were symptom-
atic as functional class 2.47 ± 0.51 while patients with mild
mitral stenosis and the control were asymptomatic.
As regards TTE data patients with mitral stenosis (severe
and mild) had a larger left atrial diameter and area than the
control {50.5 ± 3.8 & 46.2 ± 4.5 vs 35.4 ± 1.8, and 31.2 ±
3.3 & 26 ± 2.3 vs 19.9 ± 1.4} P-value 0.0001& 0.0001,
respectively.
Table 1 Clinical data of patients and control groups.
Variables Severe MS (no = 19) Mild MS (no = 24) Control (no = 12) P
Age 40.1 ± 10.2 34.8 ± 11.9 41.9 ± 12.8 0.18
Men n. (%) 3 (16%) 4 (17%) 2 (17%) 0.31
Women n. (%) 16 (84%) 20 (83%) 10 (83%) 0.34
Fc (NYHA) 2.47 ± 0.51 1 ± 0 – 0.001
HR (bpm) 82.7 ± 3.5 81.7 ± 2.1 80.5 ± 1.2 0.06
FC, functional class; HR, heart rate; bpm, beats per minute.
Table 2 TTE parameters of patients and control groups.
Variables Severe MS (no = 19) Mild MS (no = 24) Control group (no = 12) P
RV (mm) 19 ± 0.7 18 ± 1.1 19 ± 0.9 0.28
LVDD (mm) 44.7 ± 1.7 46 ± 1.5 48 ± 2.3 0.001
LVSD (mm) 25.2 ± 2.7 25.8 ± 1.9 25.8 ± 2.7 0.71
FS (%) 36 ± 2 37.5 ± 4 38 ± 2.1 0.70
LA (mm) 50.5 ± 3.8 46.2 ± 4.5 35.4 ± 1.8 0.0001
LA area (cm2) 31.2 ± 3.3 26 ± 2.3 19.9 ± 1.4 0.0001
MVA(cm2) 0.83 ± 0.18 1.8 ± 0.15 – 0.0001
Mean transmitral gradient (mm hg) 15 ± 2.8 6.7 ± 0.9 – 0.0001
PASP (mm hg) 50.9 ± 10.5 30 ± 7 25.2 ± 1.6 0.0001
RV, right ventricle; EDD, end diastolic diameter; ESD, end systolic diameter; FS, fractional shortening; LA, left atrium; MVA, mitral valve
area; PASP, pulmonary artery systolic pressure.
Table 3 TEE parameters of patients and control groups.
Variables Severe MS (no = 19) Mild MS (no = 24) Control group (no = 12) P
SEC 1.5 ± 0.44 0.82 ± 0.26 – 0.0001
LAA length (mm) 49.8 ± 6.3 42 ± 2.5 37.8 ± 2.2 0.0001
LAA base (mm) 27.7 ± 3.8 23.2 ± 3.1 18 ± 2.5 0.0001
LAA area (cm2) 7.6 ± 0.6 6.5 ± 0.5 4.6 ± 0.7 0.0001
Peak S velocity, LAA(cm/s) 16.1 ± 3.7 26.5 ± 0.7 70 ± 13 0.0001
Sm LAA (cm/s) 6 ± 1.7 12.6 ± 3 18.8 ± 1.9 0.0001
Sm RAA (cm/s) 16.5 ± 2.9 17.7 ± 1.6 20.1 ± 2.6 0.0001
LAA neck (mm) 3.2 ± 0.2 2.1 ± 0.1 2 ± 0,03 0.0001
RAA neck (mm) 3.8 ± 0.2 3.7 ± 0.18 3.3 ± 0.09 0.0001
SEC, spontaneous echo contrast; LAA, left atrial appendage; RAA, right atrial appendage; Sm, atrial peak myocardial velocity.
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PASP than the control {50.9 ± 10.5 & 30 ± 7 vs 25.2 ± 1.6}
P-value 0.0001 (see Table 2).
Patients with mitral stenosis (severe and mild) had a smaller
LVDD than the control {44.7 ± 1.7 & 46 ± 1.5 vs 48 ± 2.3}
P-value 0.001, while no signiﬁcant difference as regards other
LV parameters and right ventricular diameters.
As regards TEE data patients with mitral stenosis (severe
and mild) had a larger left atrial appendage length, base, and
area than the control {(49.8 ± 6.38 & 42 ± 2.5 vs
37.8 ± 2.2), (27.7 ± 3.8 & 23.2 ± 3.1 vs 18 ± 2.5), and
(7.6 ± 0.6 & 6.5 ± 0.5 vs 4.6 ± 0.7} P-value 0.0001. As re-
gards Doppler ﬂow of LAA, there were 2 biphasic waves a po-
sitive wave (S wave) and a negative wave (D wave), patients
with mitral stenosis (severe and mild) had a signiﬁcant decrease
in atrial peak systolic ﬂow velocities (S wave) than the control
(16.1 ± 3.7 & 26.5 ± 0.7 vs 70 ± 13), P-value 0.0001 (see
Table 3).As regards pulsed-wave tissue Doppler imaging (TDI) ﬂow
of LAA myocardial velocity, patients with mitral stenosis (se-
vere and mild) had signiﬁcant decrease in atrial peak systolic
myocardial velocities (Sm wave) of the LAA compared with
the control (6.1 ± 1.7 & 12.6 ± 0.3 vs 18.8 ± 1.9), P-value
0.0001.
Pulsed-wave tissue Doppler imaging (TDI) ﬂow of RAA
myocardial velocity, patients with mitral stenosis (severe and
mild) had a signiﬁcant decrease in atrial peak systolic myocar-
dial velocities (Sm wave) of the RAA compared with the con-
trol (16.5 ± 2.9 & 17.7 ± 1.6 vs 20.1 ± 2.6), P-value 0.0001.
SEC was detected in the LAA in 17 patients of the 43 pa-
tients with mitral stenosis which represents 39.5% of the pa-
tients. All patients with SEC were with severe MS.
Patients with SEC had a signiﬁcant increase in Fc & mean
transmitral gradient, PASP, Sm LAA, Sm RAA, LAA area
and peak S velocity LAA than patients without SEC. No pa-
tient had SEC in the RAA cavity (see Table 4).
Table 4 Echo parameters of patients with and without SEC.
Variables Patients with SEC in LAA (no = 17) Patients without SEC in LAA (no = 26) P
Age 38.5 ± 6.2 39.2 ± 6.1 0.72
FC (NYHA) 2.5 ± 0.5 1.5 ± 0.5 0.0001
LVDD (mm) 45.2 ± 5.1 46.4 ± 1.6 0.30
LVSD (mm) 27.1 ± 4.2 26.1 ± 1.9 0.31
FS (%) 38.2 ± 5.7 38.5 ± 5.6 0.88
LA diameter (mm) 47.4 ± 4 46.5 ± 4.8 0.51
LA area (cm2) 26.9 ± 4.6 26.07 ± 4.6 0.55
MVA (cm2) 0.99 ± 0.18 1.5 ± 0.5 0.0001
Mean transmitral gradient (mm hg) 13.2 ± 5.1 7 ± 2 0.0001
PASP (mm hg) 50.7 ± 11.7 33.3 ± 7.8 0.0001
Sm RAA (cm/s) 13.7 ± 4.1 18 ± 4 0.02
Sm LAA (cm/s) 9.7 ± 5.2 5.9 ± 1.9 0.001
Peak S velocity, LAA 15.2 ± 5.1 47.1 ± 7.5 0.0001
LAA, area (cm2) 7 ± 1.1 5.5 ± 1.3 0.001
LAA, base (mm) 23.3 ± 3.4 23.6 ± 3 0.79
LAA, length (mm) 49.4 ± 5.9 49.6 ± 5.8 0.92
MS, mitral stenosis; SEC, spontaneous echo contrast; FC, functional class; EDD, end diastolic diameter; ESD, end systolic diameter; FS,
fractional shortening; LA, left atrium; MVA, mitral valve area; PASP, pulmonary artery systolic pressure; LAA, left atrial appendage; Sm, atrial
peak myocardial velocity.
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Chronic rheumatic heart disease is the commonest cause of mi-
tral stenosis. Incidence of rheumatic MS parallels that of acute
rheumatic fever. Rheumatic involvement is present in 99% of
the stenotic mitral valves excised at the time of mitral valve
replacement.21 The risk of embolic complications in MS has
been known for decades22 and increases with LA size.23 Anti-
coagulation therapy with a target international normalized ra-
tio of 2–3 is indicated in patients with MS and permanent or
paroxysmal atrial ﬁbrillation, a history of embolism, or LA
thrombus.24,25 In patients with mitral stenosis (MS) in sinus
rhythm (SR), guidelines recommend anticoagulation if the left
atrium is enlarged based on diameter measurements.26 LAA
function depends on complex factors including age, heart rate,
rhythm, and loading conditions. LAA contractility is a pri-
mary determinant of LAA function. However, similar to ven-
tricular function, LAA loading conditions may affect LAA
function and ﬂow velocities.27 Today, the LAA function is
determined based on the ﬂow velocities and area change.28
Flow velocities are the main way of determining LAA function
in patients with atrial ﬁbrillation. Although ﬂow measure-
ments are controversial, there is no doubt in using area mea-
surement to determine the cardioembolic risk in patients
with sinus rhythm.29 In this study TEE was used for anatom-
ical and functional assessment of the RAA as well as LAA,
and showed that patients with MS exhibit a decrease in ﬂow
and myocardial contraction velocities of the LAA, as well as
RAA than the control group.
Patients with mitral stenosis had a dilation of the atrial
body and the LAA, with low ﬂow emptying and myocardial
contraction velocities of the LAA. Such contractile dysfunc-
tion of the LAA causes blood stasis in its cavity and favors
the presence of SEC and thrombi.30,31 The results of this
study showed that SEC present in LAA of patients with se-
vere MS, and not present in patients with mild MS, this is in
agreement with results of Hwang and Gollbasi.30,31 de Divi-
tiis et al.32 showed that the presence of SEC in the RAA ofpatients with atrial ﬁbrillation is a strong predictor of the
development of thrombi, in this study patients with MS
and sinus rhythm (severe, mild) showed that SEC is not
present in the RAA, but myocardial velocities of RAA are
reduced in patients with MS than the control, this may be
due to the increased pressure in the right atrium as a conse-
quence of increased PASP. No patient had SEC in the RAA
cavity, this ﬁnding may be explained by contractile dysfunc-
tion of the LAA (P value: 0.0001) more than that occurs in
the RAA, (P: 0.02) when compared to patients with SEC in
the LAA vs. patients without SEC. This is in agreement with
results of Subramaniam,33 he found the incidence of the
RAA thrombus formation more less in patients with MS
and atrial ﬁbrillation than in LAA.
6. Conclusion
TDI is used for the assessment of anatomical and functional
parameters of RAA as well as LAA. Patients with MS with si-
nus rhythm showed contractile dysfunction of both append-
ages demonstrated by a decrease in atrial myocardial
velocities. SEC is present in patients with severe MS, this
may explain the high incidence of thrombi in LAA with
increasing severity of MS. The RAA showed a lesser extent
of contractile dysfunction, SEC, and thrombi which were rare
in RAA.
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